Literature DB >> 19386507

Verification of the accuracy of BNCT treatment planning system THORplan.

H S Li1, Y-W H Liu, C Y Lee, T Y Lin, F Y Hsu.   

Abstract

THORplan is a treatment planning system developed at Tsing Hua University, Taiwan, for boron neutron capture therapy (BNCT) purpose. It is recently developed with user-friendly interface using Interactive Data Language. In this article the accuracy of THORplan is verified by comparing results of Snyder phantom calculation with the analytical model results of MCNP. Neutron source from THOR epithermal neutron beam is used as the source for the calculation. The thermal neutron flux calculated by THORplan is very close to the reference results. SERA overestimates thermal neutron flux by 2-5%. NCTPlan underestimates thermal neutron flux by 4-9% in most locations. The total weighted dose calculated by THORplan is accurate to within 3% except at the tissue interface. SERA overestimates the total weighted dose at depth >1.5 cm by 2-5%. NCTPlan underestimates the total weighted dose by approximately 10% at depth >1cm.

Entities:  

Mesh:

Year:  2009        PMID: 19386507     DOI: 10.1016/j.apradiso.2009.03.029

Source DB:  PubMed          Journal:  Appl Radiat Isot        ISSN: 0969-8043            Impact factor:   1.513


  3 in total

Review 1.  A Critical Review of Radiation Therapy: From Particle Beam Therapy (Proton, Carbon, and BNCT) to Beyond.

Authors:  Yoshitaka Matsumoto; Nobuyoshi Fukumitsu; Hitoshi Ishikawa; Kei Nakai; Hideyuki Sakurai
Journal:  J Pers Med       Date:  2021-08-23

Review 2.  Clinical trials for treating recurrent head and neck cancer with boron neutron capture therapy using the Tsing-Hua Open Pool Reactor.

Authors:  Ling-Wei Wang; Yen-Wan Hsueh Liu; Fong-In Chou; Shiang-Huei Jiang
Journal:  Cancer Commun (Lond)       Date:  2018-06-19

3.  A comparison of dose distributions in gross tumor volume between boron neutron capture therapy alone and combined boron neutron capture therapy plus intensity modulation radiation therapy for head and neck cancer.

Authors:  Jia-Cheng Lee; Keh-Shih Chuang; Yen-Wan Hsueh Liu; Tzung-Yi Lin; Yi-Chiao Teng; Ling-Wei Wang
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.